CLOVER GROUP PRACTICE — All Prescriptions & Medications — Page 7
Practice Code: C88069 | SHEFFIELD, S9 4QH
Showing results 301-350 of 708
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Olopatadine | 108 | 740 | £723 | +146.2% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 107 | 13.5K | £692 | -52.7% ▼ |
| Pramipexole | 107 | 5,471 | £1.3K | +9.0% ▲ |
| Alkyl sulphate | 107 | 35.7K | £819 | +1,057.8% ▲ |
| Mesalazine (Systemic) | 105 | 12.0K | £5.9K | -56.2% ▼ |
| Minoxidil | 105 | 3,814 | £1.8K | +842.1% ▲ |
| Promethazine teoclate | 105 | 4,401 | £649 | +948.9% ▲ |
| Terbinafine hydrochloride | 105 | 4,222 | £1.9K | +69.9% ▲ |
| Glucose | 105 | 7,385 | £628 | +101.9% ▲ |
| Galantamine | 104 | 2,330 | £2.0K | +174.8% ▲ |
| Phenytoin sodium | 103 | 5,460 | £1.0K | +27.5% ▲ |
| Diethylamine salicylate | 102 | 7,100 | £221 | +277.8% ▲ |
| Escitalopram | 101 | 3,206 | £176 | -64.5% ▼ |
| Mycophenolate mofetil | 101 | 9,121 | £1.0K | +149.4% ▲ |
| Powder extensively hydrolysed formula (0913101) | 101 | 254.0K | £7.2K | +40.2% ▲ |
| Fluticasone propionate (Nasal) | 101 | 704 | £1.2K | -30.6% ▼ |
| 101 | 101 | £502 | +96.9% ▲ | |
| Prednisolone | 98 | 2,358 | £254 | +36.2% ▲ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 98 | 541.8K | £10.2K | +156.8% ▲ |
| Other individually formulated bought in preparations | 98 | 43.8K | £1.1K | +200.0% ▲ |
| Valsartan | 96 | 3,332 | £789 | +63.0% ▲ |
| Nitrazepam | 96 | 1,865 | £102 | +84.8% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 96 | 12.5K | £807 | -46.6% ▼ |
| Alverine citrate | 94 | 8,131 | £374 | +127.2% ▲ |
| Terbutaline sulphate | 93 | 187 | £1.0K | +71.5% ▲ |
| Glimepiride | 93 | 2,048 | £69 | +0.8% vs avg |
| 93 | 2,068 | £477 | +136.0% ▲ | |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 92 | 1,994 | £110 | +129.0% ▲ |
| Dexamethasone | 91 | 988 | £370 | +52.4% ▲ |
| Ursodeoxycholic acid | 89 | 9,339 | £3.5K | +34.5% ▲ |
| Moxonidine | 89 | 1,680 | £221 | +59.9% ▲ |
| Dorzolamide | 89 | 2,215 | £1.1K | +7.1% ▲ |
| Ondansetron hydrochloride | 88 | 6,648 | £3.0K | +81.4% ▲ |
| Estradiol | 88 | 1,828 | £1.6K | -67.4% ▼ |
| 88 | 204 | £2.4K | +168.2% ▲ | |
| 88 | 10.1K | £587 | -32.8% ▼ | |
| Timolol and bimatoprost | 87 | 351 | £1.2K | -42.7% ▼ |
| Adapalene | 87 | 4,050 | £1.4K | +297.5% ▲ |
| 87 | 14.4K | £496 | +74.3% ▲ | |
| Trospium chloride | 86 | 2,765 | £1.3K | +68.4% ▲ |
| Potassium chloride | 85 | 1,378 | £355 | +354.7% ▲ |
| Lacosamide | 84 | 6,186 | £673 | +56.3% ▲ |
| Verapamil hydrochloride | 83 | 2,961 | £187 | -8.5% ▼ |
| Midazolam hydrochloride | 83 | 307 | £6.9K | +475.9% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 83 | 54.4K | £840 | +262.2% ▲ |
| Pimecrolimus | 82 | 3,030 | £1.9K | +384.3% ▲ |
| 81 | 32.8K | £2.1K | +112.5% ▲ | |
| 81 | 930 | £3.0K | +163.6% ▲ | |
| Amisulpride | 80 | 2,273 | £1.0K | +13.8% ▲ |
| Biphasic insulin aspart | 80 | 572 | £3.3K | -21.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.